Safety and Efficacy of Sitagliptin Added to Insulin Therapy for Type 2 Diabetes
NCT01855087 · Status: COMPLETED · Type: OBSERVATIONAL
Last updated 2013-05-16
Summary
There is paucity of information about the combination therapy with dipeptidyl peptidase-4 inhibitor sitagliptin and insulin. This study aimed to retrospectively investigate the safety and efficacy of this therapeutic modality in Japanese patients with type 2 diabetes.
Conditions
Sponsors & Collaborators
-
The Japan Kidney Foundation
collaborator OTHER -
Kanagawa Physicians Association
lead OTHER
Eligibility
- Min Age
- 20 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Primary Completion
- 2013-03-31
Countries
- Japan
Study Locations
More Related Trials
-
Double-blind Sitagliptin Add-on Study in Japanese Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Ipragliflozin (MK-0431J-842)
NCT02577016 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of the Addition of Canagliflozin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin and Sitagliptin
NCT02025907 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy of Sitagliptin and Glibenclamide on the Glucose Variability in Japanese Participants With Type 2 Diabetes Mellitus (MK-0431-355)
NCT02318693 ·Status: COMPLETED ·Phase: PHASE4
-
A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Insulin With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-254)
NCT01590797 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (Explores What the Body Does to the Drug), and Pharmacodynamics (Explores What a Drug Does to the Body) of JNJ-38431055 in Volunteers With Type 2 Diabetes Mellitus
NCT00871507 ·Status: COMPLETED ·Phase: PHASE1
-
Study of Sitagliptin in Older Type 2 Diabetics (0431-047)(COMPLETED)
NCT00305604 ·Status: COMPLETED ·Phase: PHASE3
-
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)
NCT00509262 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of the Efficacy and Safety of Albiglutide in Subjects With Type 2 Diabetes With Renal Impairment.
NCT01098539 ·Status: COMPLETED ·Phase: PHASE3
-
Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and End-Stage Renal Disease (MK-0431-073 AM1)
NCT00509236 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Investigating Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GSK2330672 Administered With Metformin to Type 2 Diabetes Patients
NCT02202161 ·Status: COMPLETED ·Phase: PHASE2
-
A Study in China Evaluating the Safety and Efficacy of Adding Sitagliptin to Stable Therapy With Sulfonylurea With or Without Metformin in Participants With Type 2 Diabetes Mellitus (T2DM) (MK-0431-253)
NCT01590771 ·Status: COMPLETED ·Phase: PHASE3
-
Sitagliptin Comparative Study in Patients With Type 2 Diabetes (0431-049)
NCT00449930 ·Status: COMPLETED ·Phase: PHASE3
-
Triple Combination Therapy in Type 2 Diabetic Patients Who Had Inadequate Glycemic Control With Combination Therapy
NCT02338921 ·Status: COMPLETED ·Phase: PHASE4
-
A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes
NCT02254291 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Sitagliptin in Glycemic Control in Real World
NCT01316835 ·Status: UNKNOWN
-
Safety/Efficacy of Sitagliptin in Patient w/ Type 2 Diabetes (0431-801)
NCT00541775 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety Study of Vildagliptin in Patients With Type 2 Diabetes
NCT01159249 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Sitaglpitin on Endothelial Function During the OGTT in T2DM
NCT02301806 ·Status: UNKNOWN ·Phase: PHASE4
-
Adding Sitagliptin or Pioglitazone to Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin and Sulfonylurea
NCT01195090 ·Status: COMPLETED ·Phase: PHASE4
-
Sitagliptin in Prevention of Type 2 Diabetes Mellitus
NCT01038648 ·Status: WITHDRAWN ·Phase: PHASE3
-
Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)
NCT00704132 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Test the Safety and Efficacy of Adding Sitagliptin in Patients With Type 2 Diabetes Mellitus (MK0431-074)
NCT00813995 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients
NCT02173457 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Study on Sitagliptin for Assessment of Glucose-lowering Effects (0431-045)
NCT00758069 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)
NCT00832390 ·Status: COMPLETED ·Phase: PHASE4